Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT07185204
Eligibility Criteria:
Inclusion Criteria:
* Pregnant patients ≥ 36 weeks gestation without major fetal anomalies
* Age ≥ 18 years
* Admitted for labor at Dhulikhel Hospital, or intend to deliver at Dhulikhel Hospital
* At risk for preeclampsia, using the Clinical Risk Assessment for Preeclampsia according to ACOG and USPSTF
* 1 or more high risk factors:
* History of preeclampsia
* Type 1 or 2 diabetes
* Multifetal gestation?
* Renal disease
* Autoimmune disease
* 2 or more moderate risk factors:
* Nulliparity
* BMI \> 30
* First-degree relative with a history of preeclampsia
* African American race
* Low socioeconomic status
* Age \> 35 years
* History of low birthweight or small for gestational age
* Previous adverse pregnancy outcome
* Interpregnancy interval \> 10 years
Exclusion Criteria:
* Antenatal hypertensive disorder of pregnancy diagnosis, including gestational hypertension, preeclampsia, eclampsia, or HELLP syndrome, according to ACOG guidelines
* Chronic hypertension, according to ACOG guidelines
* Known allergy or contraindication to nifedipine
* Inability or unwillingness to provide informed consent
* Two or more blood pressures with an SBP ≥140 or DBP ≥90 after consent and prior to sFlt-1/PlGF testing (screen failure criteria)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07185204
Study Brief:
Protocol Section:
NCT07185204